pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
LACTATED RINGER'S IN PLASTIC CONTAINER
LACTATED RINGER'S IN PLASTIC CONTAINER (CALCIUM CHLORIDE)
no indication
Baxter Healthcare Corp
LACTATED RINGERS
LACTATED RINGERS (SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE)
no indication
BAXTER HLTHCARE
Phase 2
LACTIN-V
LACTIN-V
Bacterial Vaginosis
Osel Inc
LACTULOSE SOLUTION
LACTULOSE SOLUTION (LACTULOSE SOLUTION USP, 10 G/15 ML)
← prev
page 116 of 271
next →
Pain
89
Neurology
1
no indication
BAJAJ
Preclinical
LADR-7
Head And Neck Squamous Cell Carcinoma (HNSC)
LadRx Corp
Phase 1
LAE-102
Obesity
Laekna Inc
Marketed
LAMICTAL
LAMICTAL (LAMOTRIGINE)
Bipolar Disorder (Manic Depression)
GlaxoSmithKline LLC
LAMICTAL CD
LAMICTAL CD (LAMOTRIGINE)
no indication
GlaxoSmithKline LLC
LAMICTAL ODT
LAMICTAL ODT (LAMOTRIGINE)
no indication
GlaxoSmithKline LLC
LAMICTAL XR
LAMICTAL XR (LAMOTRIGINE)
no indication
GlaxoSmithKline LLC
LAMIVUDINE AND ZIDOVUDINE
LAMIVUDINE AND ZIDOVUDINE
no indication
MACLEODS PHARMS LTD
LANOXIN PEDIATRIC
LANOXIN PEDIATRIC (DIGOXIN)
no indication
Azurity Pharmaceuticals Inc
LANSOPRAZOLE
LANSOPRAZOLE
no indication
Dexcel Pharma Ltd
LARIN 1.5/30
LARIN 1.5/30 (NORETHINDRONE ACETATE/ETHINYL ESTRADIOL)
no indication
NOVAST LABS
LASIX ONYU
LASIX ONYU (FUROSEMIDE)
no indication
SQ Innovation AG
Phase 2
LASN-01
Graves' Ophthalmopathy
Lassen Therapeutics 1 Inc
Phase 2
LAT-010
Breast Cancer
Latticon Antibody Therapeutics Inc
Preclinical
LATANOPROST
LATANOPROST
Open-Angle Glaucoma
Rebio Technologies Ltd
LAZCLUZE
LAZCLUZE (LAZERTINIB MESYLATE)
no indication
Janssen Biotech Inc
Phase 2
LB-100
Myelodysplastic Syndrome (Preleukemia)
$LIXT
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
Phase 3
LB-102
Schizophrenia
$LBRX
LB PHARMACEUTICALS INC
Preclinical
LB-104
Depression
$LBRX
LB PHARMACEUTICALS INC
Phase 1
LB-1908
Adenocarcinoma Of The Gastroesophageal Junction
$LEGN
Legend Biotech Corp
Phase 2
LB-2102
Neuroendocrine Carcinoma
$NVS
NOVARTIS AG
Preclinical
LB-P4
Alzheimer's Disease
LISCure Biosciences Inc
Phase 2
LB-P8
Primary Sclerosing Cholangitis
LISCure Biosciences Inc
Preclinical
LBL-043
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Nanjing Leads Biolabs Co Ltd
Preclinical
LBL-049
Cancer Anorexia-Cachexia Syndrome
Nanjing Leads Biolabs Co Ltd
Preclinical
LBL-051
Lupus Nephritis
Nanjing Leads Biolabs Co Ltd
Preclinical
LBL-061
Head And Neck Squamous Cell Carcinoma (HNSC)
Nanjing Leads Biolabs Co Ltd
